CHINESE drug regulatory authorities have approved a new anti-insomnia medication, according to Chinese media reports. Simcere Pharmaceutical Group...
Vous n'êtes pas connecté
CHINESE drug regulatory authorities have approved a new anti-insomnia medication, according to Chinese media reports. Simcere Pharmaceutical Group Ltd., a Hong Kong-listed company headquartered in Nanjing, Jiangsu Province, announced that the National Medical Products Administration has approved Quviviq for the...
CHINESE drug regulatory authorities have approved a new anti-insomnia medication, according to Chinese media reports. Simcere Pharmaceutical Group...
Hong Kong as a regulatory laboratory for Bitcoin and stablecoin
620 years ago, the renowned Chinese navigator Admiral ZHENG He commanded the world’s then most advanced wooden fleet, setting sail from...
620 years ago, the renowned Chinese navigator Admiral ZHENG He commanded the world’s then most advanced wooden fleet, setting sail from...
HONG KONG SAR – Media OutReach Newswire – 04 April 2025 – DL Holdings Group, a company listed on the Hong Kong Stock Exchange Main Board (stock...
HONG KONG SAR – Media OutReach Newswire – 04 April 2025 – DL Holdings Group, a company listed on the Hong Kong Stock Exchange Main Board (stock...
July 2, 2025 – Dizal (SSE:688192), a biopharmaceutical company committed to developing novel medicines for the treatment of cancer and...
US drug regulators have increasingly signaled a focus on faster approvals and rare diseases, but patients with ultra-rare ailments fear they are...
US drug regulators have increasingly signaled a focus on faster approvals and rare diseases, but patients with ultra-rare ailments fear they are...
HONG KONG–(BUSINESS WIRE)–Alibaba Group Holding Limited (NYSE: BABA and HKEX: 9988 (HKD Counter) and 89988 (RMB Counter), “Alibaba,”...